Saskia C de Jager
Overview
Explore the profile of Saskia C de Jager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
2.
Martins-Marques T, Ribeiro-Rodrigues T, de Jager S, Zuzarte M, Ferreira C, Cruz P, et al.
Life Sci Alliance
. 2020 Oct;
3(12).
PMID: 33097557
Ischemic heart disease has been associated with an impairment on intercellular communication mediated by both gap junctions and extracellular vesicles. We have previously shown that connexin 43 (Cx43), the main...
3.
4.
van Puijvelde G, Foks A, van Bochove R, Bot I, Habets K, de Jager S, et al.
PLoS One
. 2018 Jan;
13(1):e0190962.
PMID: 29346401
An abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta leading to serious complications and mostly to death. AAA development is associated with an accumulation of inflammatory cells...
5.
Best M, Sol N, In t Veld S, Vancura A, Muller M, Niemeijer A, et al.
Cancer Cell
. 2017 Aug;
32(2):238-252.e9.
PMID: 28810146
Blood-based liquid biopsies, including tumor-educated blood platelets (TEPs), have emerged as promising biomarker sources for non-invasive detection of cancer. Here we demonstrate that particle-swarm optimization (PSO)-enhanced algorithms enable efficient selection...
6.
Maiwald S, Sivapalaratnam S, Motazacker M, van Capelleveen J, Bot I, de Jager S, et al.
PLoS One
. 2014 Jun;
9(5):e98289.
PMID: 24879339
Aims: Genetic factors explain a proportion of the inter-individual variation in the risk for atherosclerotic events, but the genetic basis of atherosclerosis and atherothrombosis in families with Mendelian forms of...
7.
Lucerna M, Zernecke A, de Nooijer R, de Jager S, Bot I, van der Lans C, et al.
Blood
. 2006 Sep;
109(1):122-9.
PMID: 16990600
Vascular endothelial growth factor-A is widely used in clinical trials for the treatment of cardiac ischemia. VEGF-A was recently suggested to act in a proinflammatory manner, which could aggravate adjacent...
8.
Dekker R, van Thienen J, Rohlena J, de Jager S, Elderkamp Y, Seppen J, et al.
Am J Pathol
. 2005 Jul;
167(2):609-18.
PMID: 16049344
Lung Krüppel-like factor (LKLF/KLF2) is an endothelial transcription factor that is crucially involved in murine vasculogenesis and is specifically regulated by flow in vitro. We now show a relation to...